Nutraceuticals and nootropics for anti-aging

CDP-choline and age-related memory decline

A recent study of CDP-choline supplementation has shown that rats do not suffer the memory deficits that typically develop in unsupplemented rats as they age. This study was performed at the Massachusetts Institute of Technology and reported in the June issue of Progress in neuro-psychopharmacology & biological psychiatry. CDP-choline was supplied to the rats at dose of about 500 mg/kg/day. How this translates into a human dose is anyone’s guess at this stage; however, doses of 500 mg/day are typically used for human cognitive improvement, based on previous studies.

The implication of these exciting results is that CDP-choline may be a preventative for a very common form of age-related cognitive decline.

Link to the research abstract:

Dietary cytidine (5')-diphosphocholine supplementation protects against development of memory deficits in aging rats.